7th ACE Drug Discovery Summit
06th – 07th May 2026
About Us
The 7th Ace Drug Discovery Summit USA 2026 is a premier scientific forum uniting global researchers, biotech leaders, and pharma innovators to explore the latest advancements transforming drug discovery. This two-day summit features cutting-edge sessions on AI-driven drug design, quantum computing in simulation, targeted protein degradation, RNA therapeutics, and sustainable medicinal chemistry. Key discussions will highlight CAR-T cell therapies, immunotherapy combinations, bioinformatics, and nanomedicine, reflecting the evolving landscape of pharmaceutical R&D. Attendees will gain actionable insights into emerging technologies, fragment-based drug design, and AI-powered screening, with a strong focus on unmet medical needs and ethical considerations. With interactive panel discussions, expert-led presentations, and exclusive business meetings, the summit fosters meaningful collaboration and knowledge exchange across the drug development spectrum. Join us to stay at the forefront of innovation and reshape the future of drug discovery and therapeutic development.
Why Attend





Solutions at ADDS
The 7th Ace Drug Discovery Summit USA 2026 is a premier scientific forum uniting global researchers, biotech leaders, and pharma innovators to explore the latest advancements transforming drug discovery.
🔷Antibody Engineering
🔷Biochemistry
🔷Bio-informatics
🔷ADMUPI (Toxicology)
🔷Biomarker Validation
🔷Combinatorial Chemistry
🔷Covering Biological studies
🔷Data Management TechnologyÂ
🔷Digital Imaging Technology
🔷Discovery Outsourcing Services
🔷DNA & RNA Analysis
🔷DNA Sequencing Services
🔷 Drug Discovery Technology Platforms
🔷Gene Expression Profiling Solutions
🔷Preclinical
🔷Principal Scientists
🔷Protein identification Services
🔷Research & Development
🔷Transgenesis Services
🔷Genomics
🔷High Throughput Screening
🔷Lead Optimatisation and Profiling, HTS
🔷 Licensing
🔷lmaging/biomarker
🔷Imaging Tools
Who Will Attend
The 7th Ace Drug Discovery Summit USA 2026 is a premier scientific forum uniting global researchers, biotech leaders, and pharma innovators to explore the latest advancements transforming drug discovery
🔷CEO
🔷CSO
🔷Director Discovery Alliances
🔷Director of Discovery Strategy Portfolio
🔷Director of Screening & Compound   Profiling
🔷Executive Director Chemistry
🔷Head of DMPK
🔷Head of Drug Design
🔷Head of Molecular Toxicology
🔷VP Target Discovery & Assessment
🔷Head of R&D Licensing
🔷Head Pharmacology & Toxicology
🔷Principal Scientist
🔷Senior Director Discovery Research
Thought Leaders
Hanjnalka Hartl
Head of Chemistry | Orogen Therapeutics
Â
Philip M Arlen
CEO | Precision Biologics
MaryLena Bleile
Statistician | Independent
Rick Ewing
VP, Head of Chemistry | Rapafusyn Pharmaceuticals
Kevin Knopf
Medical OncologistÂ
Xin Zhang
Sr. Director, Computational Chemistry | Cellarity
Chester Yuan
CSO |
Sungening Biosciences
Michael Liebman
Managing Director |
IPQ Analytics/WOVEN
Shicheng Guo
Senior Director |
Arrowhead Pharmaceuticals
Vivek Gupta
Associate Professor |
St. John’s University
Igor Nasonkin
CEO |
Phythera Therapeutics
Julia Coronella
Former Vice President of Immuno-oncology |
Poseida Therapeutics, Inc.
Tyler Umansky
Head of Platform and Machine Learning |
Model Medicines
Adwitiya Kar
Former Senior Scientist |
Immunitas Therapeutics
Noah Davidsohn
Co-Founder & Chief Scientific Officer |
Rejuvenate Bio
Bo Chen
Associate Director, Drug Discovery |
Arrowhead Pharmaceuticals
Tammy Lyons
Sr. Events and Marketing Manager |
Weave Bio
Amy He
Research Scientist |
Topos Bio
Rose Yu
Associate Professor |
UC San Diego
Rameshwar Kadam
Senior Scientist II |
Johnson and Johnson Innovative Medicine
Jitendra Kumar
Lead Scientist: Chemistry and Process Development |
Entos Pharmaceuticals US, Inc.
Our Sponsors
Attendee Breakdown
Attendee Demographics
Agenda
06 May
Computer-Aided Drug Discovery
The Future of Pharmaceuticals
Advances in Targeted Protein Degradation for Drug Discovery
Future Perspectives for AI in the Drug Discovery
Proteomics Applications
Traditional Resources and Tools for Modern Drug Discovery
Different Approaches to Engage T Cells for Solid Tumors
07 May
        Fragment-Based Drug Design
Emerging Technologies for Discovery Chemistry
How Drug Discovery Applications Drive AI InnovationsÂ
Novel Approaches to Target RNA Structure
Nanomedicine in Drug Discovery
AI-Driven Drug Design and Lead Optimization
Rise Of Scientific Superintelligence
Our Partners
Marriott International begins as an A&W Root Beer franchise in Washington, D.C., in May 1927, with the same core values that guide the company today. Founders J. Willard and Alice Sheets Marriott get their business started by quenching people’s thirst during the hot, muggy summers in Washington, D.C., before serving food and becoming The Hot Shoppes, and entering other lines of business. Heralding in a new era in 2016, Marriott International acquires Starwood Hotels & Resorts Worldwide creating the world’s largest hotel company. There is a celebration in New York City’s Time Square.
